Compulsive sexual behaviour – European Clinical Trials Information Network https://clinicaltrials.eu Bridging Patients with Clinical Trials Fri, 12 Jun 2026 11:24:45 +0000 en-US hourly 1 https://wordpress.org/?v=7.0 https://clinicaltrials.eu/wp-content/uploads/2024/12/cropped-EU_icon-32x32.png Compulsive sexual behaviour – European Clinical Trials Information Network https://clinicaltrials.eu 32 32 Comparing cognitive behavioral therapy alone versus cognitive behavioral therapy combined with degarelix to prevent sexual offenses in patients with paraphilic disorders https://clinicaltrials.eu/trial/comparing-cognitive-behavioral-therapy-alone-versus-cognitive-behavioral-therapy-combined-with-degarelix-to-prevent-sexual-offenses-in-patients-with-paraphilic-disorders/ Thu, 30 Apr 2026 13:08:51 +0000 https://clinicaltrials.eu/trial/comparing-cognitive-behavioral-therapy-alone-versus-cognitive-behavioral-therapy-combined-with-degarelix-to-prevent-sexual-offenses-in-patients-with-paraphilic-disorders/ This study aims to assess the effectiveness of combining Cognitive Behavioral Therapy, a type of talk therapy that helps people change unhelpful thoughts and behaviors, with medication to reduce the risk of sexual offenses in individuals with Paraphilic disorder or Compulsive sexual behavior disorder. Participants may receive degarelix, a medication used to suppress hormone levels, alongside the therapy. In some cases, testosterone cipionate, a form of testosterone, may be provided through a gel applied to the skin to manage certain effects of the suppression medication.

The study compares different treatment approaches. Some participants will receive only the talk therapy, while others will receive the therapy combined with degarelix or a placebo. This research looks at how these different combinations affect behaviors and symptoms over time. Participants will be monitored for a period of time to observe changes in their behavior and physical health.

]]> Study on the Effects of Escitalopram, Naltrexone, and Their Combination on Reducing Symptoms of Compulsive Sexual Behavior Disorder in Affected Patients https://clinicaltrials.eu/trial/study-on-the-effects-of-escitalopram-naltrexone-and-their-combination-on-reducing-symptoms-of-compulsive-sexual-behavior-disorder-in-affected-patients/ Wed, 29 Apr 2026 15:03:48 +0000 https://clinicaltrials.eu/trial/study-on-the-effects-of-escitalopram-naltrexone-and-their-combination-on-reducing-symptoms-of-compulsive-sexual-behavior-disorder-in-affected-patients/ This clinical trial is focused on studying the effects of different treatments for Compulsive Sexual Behavior Disorder (CSBD). CSBD is a condition where individuals find it difficult to control intense sexual urges, leading to repetitive sexual behaviors that can interfere with daily life. The study will explore the effectiveness of three different treatments: Escitalopram, Naltrexone, and a combination of both, as well as a placebo. Escitalopram is commonly used to treat depression and anxiety, while Naltrexone is often used to manage addiction by reducing cravings.

The purpose of the study is to compare how these treatments affect the severity of CSBD symptoms. Participants will receive one of the treatments or a placebo and will be monitored over a period of time to observe changes in their symptoms. The study will involve taking medication orally, which means swallowing a pill, and participants will be asked to keep a diary to track their behaviors and feelings.

Throughout the study, participants will be assessed using various scales and questionnaires to measure the frequency and intensity of their compulsive sexual behaviors. The study aims to provide insights into which treatment is most effective in reducing the symptoms of CSBD, potentially offering new options for managing this condition.

]]> Study on the Effects of Escitalopram, Paroxetine, and Naltrexone for Patients with Compulsive Sexual Behavior Disorder https://clinicaltrials.eu/trial/study-on-the-effects-of-escitalopram-paroxetine-and-naltrexone-for-patients-with-compulsive-sexual-behavior-disorder/ Wed, 29 Apr 2026 14:58:53 +0000 https://clinicaltrials.eu/trial/study-on-the-effects-of-escitalopram-paroxetine-and-naltrexone-for-patients-with-compulsive-sexual-behavior-disorder/ This clinical trial is focused on studying the effects of different treatments for Compulsive Sexual Behavior Disorder (CSBD). The treatments being tested include medications such as escitalopram, paroxetine, naltrexone, and a combination of escitalopram and naltrexone. There is also a group receiving a placebo. The purpose of the study is to compare how these treatments affect the symptoms of CSBD.

Participants in the study will take one of the medications or a placebo for a period of time. The study will monitor changes in the severity of their symptoms, which include behaviors like viewing pornography, masturbation, or using paid sexual services. The study aims to see if these treatments can help reduce the frequency and intensity of these behaviors.

The trial will involve regular check-ins where participants will report on their symptoms and any changes they experience. This information will help researchers understand which treatment is most effective in managing CSBD. The study is expected to continue for several years to gather comprehensive data on the effectiveness of these treatments.

]]>